Tarek Mouhieddine, MD @tarekmd91 profile

Tarek Mouhieddine, MD

@tarekmd91

Followers

2K

Following

8K

Statuses

1K

@AUB_Lebanon | @DanaFarber | @IcahnMountSinai | @SinaiHemeOnc Fellow @TischCancer | Physician-scientist #multiplemyeloma #myeloma #mmsm 🇱🇧🇺🇸

New York, NY

Joined October 2011

Don't wanna be here? Send us removal request.

Tarek Mouhieddine, MD

@tarekmd91

8 days

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53 | New England Journal of Medicine

0

7

Tarek Mouhieddine, MD

@tarekmd91

9 days

Promising Early Data for Improving Talquetamab Effectiveness for MM | via @YouTube @HealthTree @ASH_hematology @IcahnMountSinai @TischCancer @SinaiHemeOnc #ASH24 #mmsm #multiplemyeloma

0

7

Tarek Mouhieddine, MD

@tarekmd91

16 days

RT @JoshuaRichterMD: Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead - ScienceDirect. ⁦@tarekmd…

0

6

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

@NBahlis Hope you’re well Nizar 🙏 Merry Christmas to you and your family 🎄

0

2

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @FrancescoMaura4: Just before the holidays, new preprint from the lab on @biorxivpreprint! Super talented @BenDiamondMD reports CD38 los…

0

22

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @TischCancer: Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma

0

6

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @IrenemGhobrial: Pangea 2.0 risk stratification in >2000 smoldering MM. thanks to all our collaborators. We can predict progression earl…

0

7

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @HiraSMian: Joshua up on stage, yes the big room! @JoshuaRichterMD

0

4

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @MyelomaTeacher: Thank you @JoshuaRichterMD and @tarekmd91 for stopping by. I am learning about bench to bedside research happening in…

0

7

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

@MeeraMohanMD @ASH_hematology Thank you @MeeraMohanMD !

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @MeeraMohanMD: GPRC5D alterations were noted in 35% of patients at the end of treatment Excellent work @tarekmd91 #ASH24 #MMSM @ASH_hem…

0

6

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @mdbrunocosta: Outstanding presentation by @tarekmd91 from @TischCancer on combined PD-1 and Tim-3 blockade to enhance anti-myeloma T ce…

0

6

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

@GKaurMD I’m looking forward to seeing all your tweets! As well as those by @RahulBanerjeeMD 😁

0

2

Tarek Mouhieddine, MD

@tarekmd91

2 months

@TischCancer @SantiagoThibaud @IcahnMountSinai @Zach_Avigan

0

1

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @JoshuaRichterMD: Excited to be presenting the updated data on cevostamab on Monday. Amazing collaborating docs working together for t…

0

11

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

@OgaKingsley @WinshipAtEmory Congratulations!

0

1

Tarek Mouhieddine, MD

@tarekmd91

2 months

@nickthomasmed @MSKCancerCenter Congratulations!

1

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

@mdbrunocosta @MDAndersonNews Congratulations!!! Very proud of you and very well deserved!! 👏

0

2

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @TischCancer: Our #MultipleMyeloma team has numerous presentations at #ASH24. @tarekmd91 will present on Dec 7 at 4:30: Combined PD-1 a…

0

7

0

Tarek Mouhieddine, MD

@tarekmd91

2 months

RT @Myeloma_Doc: #Myeloma Paper of the Day: Myeloma long-term survivors exhibit sustained immune alterations decades after 1st-line tx even…

0

16

0